eMedicine Specialties > Otolaryngology and Facial Plastic Surgery > Nasal & Sinus Diseases

Functional Endoscopic Sinus Surgery: Treatment

Author: Ankit Patel, MD, Staff Physician, Department of Otolaryngology-Head and Neck Surgery, St Joseph Medical Center, Silver Cross Hospital
Contributor Information and Disclosures

Updated: Mar 6, 2008

Treatment

Medical Therapy

Medical therapy is the mainstay of treatment for most patients with recurrent or chronic sinusitis. Surgery may serve as an adjunct and provide significant relief for these patients, but medical treatment should always be instituted before surgery is considered for these patients. Frequently, medical treatment is also required after surgery.

Treatment of chronic or recurrent sinusitis consists of a 3- to 6-week course of antibiotics, with coverage for gram-positive and gram-negative bacteria. Augmentin and levofloxacin are antibiotics that are typically used. Nasal steroids should be instituted to decrease intranasal edema and inflammation. Improvement with nasal steroids might not be seen for days or weeks. Saline irrigations are also important for nasal toilet. If nasal congestion is a significant complaint, a short course of decongestants (3 d if intranasal, 7 d if oral) may be used. If thick nasal mucous is noted, guaifenesin, taken orally at a high dosage (600 mg bid for 3 wk), may provide significant relief as a mucolytic.

Patients with nasal polyps may undergo the above treatment, plus a 1-week course of oral steroids (40 mg/d) beginning 5 days prior to surgery. (Steroids may decrease intraoperative bleeding and inflammation.) Patients should be carefully counseled regarding possible adverse effects, including hyperglycemia (especially in patients with diabetes), gastritis, and even psychosis. Steroids shrink polyp size and significantly improve symptoms, but the patient should be counseled that surgery is still required to eradicate the remaining nasal polyps.

After a full course of medical treatment, a paranasal CT scan should be obtained to assess treatment and to confirm radiographic evidence of chronic sinusitis. Patients with residual symptoms and radiographic findings consistent with recurrent or chronic sinusitis may be considered as candidates for surgery. If findings on CT scans do not reveal significant mucosal thickening or sinus opacification, the diagnosis of sinusitis should be reassessed. Patients with recurrent sinusitis may have normal findings on CT scans after treatment or between episodes, but they should have positive radiographic findings during episodes.

Every effort should be made to confirm the diagnosis of chronic or recurrent sinusitis prior to initiating endoscopic sinus surgery. Limited data exist for operating on patients whose clinical picture is consistent with chronic or recurrent sinusitis despite normal findings on CT scans. This finite subset of patients represents the exception, not the rule, for endoscopic sinus surgery operative candidates.

Surgical Therapy

Patients may undergo functional endoscopic sinus surgery under intravenous sedation and local anesthesia or under general anesthesia. The authors' institutional preference is general anesthesia.

The procedure begins with decongestion of the nose and infiltration of lidocaine with epinephrine (1% lidocaine with 1:100,000 epinephrine is used for injection). The lateral nasal wall near the uncinate process is injected. Using a 3-mL syringe while placing a slight bend to the 27-gauge needle facilitates the injection. Next, the superior inlet and the anterior face of the middle turbinate are injected submucosally. If the possibility of septoplasty exists, the septum should also be injected. Next, 4 mL of 4% cocaine is placed onto pledgets, which are placed bilaterally in the nares. A throat pack may be placed, or, alternatively, the stomach may be suctioned prior to extubation upon completion of the procedure. The patient is then draped for surgery. If image-guided surgery is to be used, the appropriate headset apparatus should be applied at this time.

Functional endoscopic sinus surgery may begin with uncinectomy. If the uncinate process can be initially visualized without manipulating the middle turbinate, uncinectomy can be performed directly. Otherwise, the middle turbinate is gently medialized, carefully using the curved portion of the Freer elevator to avoid mucosal injury to the turbinate and to avoid forceful medialization and fracture of the turbinate.

Next, uncinectomy may be performed via an incision with either the sharp end of the Freer elevator or a sickle knife. The incision should be placed at the most anterior portion of the uncinate process, which is softer on palpation in comparison to the firmer lacrimal bone, where the nasolacrimal duct is located. Then, a Blakesley forceps is used to grasp the free uncinate edge and to remove it. Complete uncinectomy is important for subsequent visualization. Incomplete uncinectomy is a common reason for failure with primary surgery. The backbiter may also be directly used to take down the uncinate process.

Once the uncinate process is taken down, the true natural ostium of the maxillary sinus should be identified. The protected eye may be palpated at this juncture to ensure no dehiscence of the lamina papyracea and to confirm the location of the lamina. The natural ostium is typically at the level of the inferior edge of the middle turbinate about one third of the way back. A true cutting instrument is used to circumferentially enlarge the natural ostium. The optimal diameter for the maxillary antrostomy is controversial; typically, a diameter of 1 cm allows for adequate outflow and for postoperative monitoring in the office. Care should always be taken to avoid penetrating the lamina papyracea.

Next, the ethmoid bulla should be identified and opened. A J-shaped curette may be used to open the bulla at its interior and medial aspect. Once the cell is entered, the bony portions may be carefully removed using a microdebrider or a true-cutting forceps. Complete resection of the lateral bulla facilitates proper visualization and dissection posteriorly. Again, care should be taken laterally to maintain an intact lamina papyracea.

The remainder of the anterior ethmoid cells may be uncapped initially with a J curette and further opened with a microdebrider or a true cutting forceps. Using a curette initially allows for tactile sensation and determination of the thickness of bone and verifies proper orientation prior to further opening of cells with powered instrumentation. Care should always be taken to avoid mucosal stripping because mucosal preservation results in superior postoperative outcomes.

Anterior ethmoid cells should be cleared to the skull base, with the surgeon exercising caution when approaching the ethmoid roof and maintaining constant reference both to the endoscopic view and to the preoperative CT scan. Image-guided surgery or computer-aided surgery also guides the surgeon as to the distance to the skull base, but it does not replace the need for an intimate knowledge of the anatomy. While moving posteriorly to new air cells, the surgeon should always enter inferiorly and medially and then subsequently open laterally and superiorly once the more distal anatomy can be judged by visualization and palpation. Anterior ethmoidectomy is complete upon reaching the basal lamella of the middle turbinate.

If the sinus disease is limited to the anterior ethmoid cells and the maxillary sinus, the procedure may end with simple anterior ethmoidectomy and maxillary antrostomy. If, however, significant radiographic and clinical posterior ethmoid and sphenoid disease is present, then dissection should continue to exenterate the posterior ethmoid cells and to perform adequate sphenoidotomy as appropriate.

Posterior ethmoidectomy begins with perforating the basal lamella just superior and lateral to the junction of the vertical and horizontal segments of the middle turbinate. Care must be taken to preserve the posterior sagittal section of the middle turbinate and the inferior portion of the coronal segment of the basal lamella. By preserving this L-shaped strut, the stability of the middle turbinate is ensured. The lateral and superior portions of the basal lamella may then be removed using the microdebrider. Further posterior ethmoid cells may be taken down in a similar fashion, keeping in mind the location of the skull base and the lamina. The surgeon must be cognizant that the skull base typically slopes inferior at an approximately 30° angle from anterior to posterior. Thus, the skull base lies lower posteriorly than anteriorly. This dissection is taken back to the face of the sphenoid.

In the absence of Onodi cells, the sphenoid ostium lies medial and posterior to the final posterior ethmoid cell. A rough guide is that the face of the sphenoid is approximately 7 cm from the nasal sill at a 30° angle from the horizontal. Identifying the superior turbinate aids in the confirmation of position. The superior turbinate inserts on the anterior face of the sphenoid sinus. The sphenoid sinus is entered just medial and inferior to its natural ostium with a J curette or an olive-tipped suction. Once the sinus is entered safely, the ostium can be enlarged using a mushroom punch forceps. Care must be taken not to aggressively enter the sinus because dehiscences may be present in the bony coverage of the carotid artery or the optic nerve.

Frontal sinus work is typically reserved for the end of the surgical procedure because manipulation may create bleeding and obscure further posterior work. If frontal sinus work is indicated, a 45° or a 70° telescope proves useful. Typically, an agger nasi or frontal cell is the cause of frontal outflow obstruction. Using an angled scope for visualization, a frontal sinus curette is passed above the cell and then pulled anteriorly, thus breaking posterior and superior cell walls. Particular care must be exercised when working in the frontal recess because both the lamina and the skull base sit in immediate proximity to the outflow tract. Image-guided and navigational systems for computer-aided surgery and intimate knowledge of the anatomy are critical for safe frontal sinus work. For further discussion of endoscopic frontal sinus surgery, see the text by Kuhn and Javer.

Once dissection is complete and hemostasis is achieved, a bacitracin-coated Telfa or Afrin soaked pledget is placed into the nostril. This packing is removed prior to discharge of the patient. The patient is discharged with Ocean Nasal Mist and antibiotics, as well as instructions for a follow-up visit in 1 week. Some surgeons also place Gelfilm or a dissolvable spacer within the middle meatus to keep the space open and to prevent lateralization of the middle turbinate and synechiae formation. If placed, the spacer should be removed or suctioned away on the first postoperative visit.

Pearls of wisdom regarding endoscopic sinus surgery are as follows:

  • When entering each new space or landmark (eg, bulla ethmoidalis, anterior ethmoid cells, basal lamella, posterior ethmoid cells, sphenoid), the safest location for entry is medial and inferior.
  • The patient's CT scan should be examined preoperatively for location of the skull base on coronal cuts.
  • The frontal recess is best evaluated on sagittal CT sections.
  • The uncinate process most often attaches to the lamina papyracea superiorly, thus leaving the frontal recess to drain medially and superiorly to the uncinate.
  • The sphenopalatine foramen and the sphenopalatine artery are adjacent to the lateral and inferior attachment of the basal lamella to the lamina papyracea.
  • Orbital hematoma/postoperative proptosis requires immediate removal of nasal packing, emergent ophthalmologic consultation, and emergent lateral canthotomy.

Complications

All risks and benefits should be candidly discussed with patients as part of the informed consent process prior to surgery. A patient should never undergo surgery without a full discussion of all possible complications.

Risks associated with endoscopic sinus surgery are as follows:

  • Bleeding
  • Synechiae formation
  • Orbital injury
  • Diplopia
  • Orbital hematoma
  • Blindness
  • CSF leak
  • Direct brain injury
  • Nasolacrimal duct injury/epiphora

More on Functional Endoscopic Sinus Surgery

Overview: Functional Endoscopic Sinus Surgery
Workup: Functional Endoscopic Sinus Surgery
Treatment: Functional Endoscopic Sinus Surgery
Follow-up: Functional Endoscopic Sinus Surgery
References

References

  1. Senior BA, Kennedy DW, Tanabodee J. Long-term results of functional endoscopic sinus surgery. Laryngoscope. Feb 1998;108(2):151-7. [Medline].

  2. Damm M, Quante G, Jungehuelsing M, Stennert E. Impact of functional endoscopic sinus surgery on symptoms and quality of life in chronic rhinosinusitis. Laryngoscope. Feb 2002;112(2):310-5. [Medline].

  3. Bolger WE, Brown CL, Church CA, Goldberg AN, Karanfilov B, Kuhn FA. Safety and outcomes of balloon catheter sinusotomy: a multicenter 24-week analysis in 115 patients. Otolaryngol Head Neck Surg. Jul 2007;137(1):10-20. [Medline].

  4. Atlas SJ, Metson RB, Singer DE, Wu YA, Gliklich RE. Validity of a new health-related quality of life instrument for patients with chronic sinusitis. Laryngoscope. May 2005;115(5):846-54. [Medline].

  5. [Best Evidence] Aukema AA, Mulder PG, Fokkens WJ. Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery. J Allergy Clin Immunol. May 2005;115(5):1017-23. [Medline].

  6. Barzilai G, Greenberg E, Uri N. Indications for the Caldwell-Luc approach in the endoscopic era. Otolaryngol Head Neck Surg. Feb 2005;132(2):219-20. [Medline].

  7. Bradley DT, Kountakis SE. Correlation between computed tomography scores and symptomatic improvement after endoscopic sinus surgery. Laryngoscope. Mar 2005;115(3):466-9. [Medline].

  8. Chandra RK, Kennedy DW, Palmer JN. Endoscopic management of failed frontal sinus obliteration. Am J Rhinol. Sep-Oct 2004;18(5):279-84. [Medline].

  9. Chiu AG, Palmer JN, Cohen N. Use of image-guided computed tomography-magnetic resonance fusion for complex endoscopic sinus and skull base surgery. Laryngoscope. Apr 2005;115(4):753-5. [Medline].

  10. Colclasure JC, Gross CW, Kountakis SE. Endoscopic sinus surgery in patients older than sixty. Otolaryngol Head Neck Surg. Dec 2004;131(6):946-9. [Medline].

  11. Dufour X, Kauffmann-Lacroix C, Ferrie JC, Goujon JM, Rodier MH, Karkas A. Paranasal sinus fungus ball and surgery: a review of 175 cases. Rhinology. Mar 2005;43(1):34-9. [Medline].

  12. Flynn JT, Mitchell KB, Fuller DG, London HB, Cohen HH. Ocular motility complications following intranasal surgery. Arch Ophthalmol. Mar 1979;97(3):453-8. [Medline].

  13. Han JK, Smith TL, Loehrl T, Toohill RJ, Smith MM. An evolution in the management of sinonasal inverting papilloma. Laryngoscope. Aug 2001;111(8):1395-400. [Medline].

  14. Iro H, Mayr S, Wällisch C, Schick B, Wigand ME. Endoscopic sinus surgery: its subjective medium-term outcome in chronic rhinosinusitis. Rhinology. Dec 2004;42(4):200-6. [Medline].

  15. Kennedy DW. Functional endoscopic sinus surgery. Technique. Arch Otolaryngol. Oct 1985;111(10):643-9. [Medline].

  16. Kennedy DW, Bolger WE, Zinreich SJ. Diseases of the Sinuses, Diagnosis and Management. London:. BC Decker;2001.

  17. Kuhn FA, Javer AR. Primary endoscopic management of the frontal sinus. Otolaryngol Clin North Am. Feb 2001;34(1):59-75. [Medline].

  18. May M, Levine HL, Mester SJ, Schaitkin B. Complications of endoscopic sinus surgery: analysis of 2108 patients-- incidence and prevention. Laryngoscope. Sep 1994;104(9):1080-3. [Medline].

  19. McCary WS, Gross CW, Reibel JF, Cantrell RW. Preliminary report: endoscopic versus external surgery in the management of inverting papilloma. Laryngoscope. Apr 1994;104(4):415-9. [Medline].

  20. Messerklinger W. Endoscopy of the nose. Baltimore:. Urban & Schwarzenberg;1978.

  21. Nouraei SA, Hajioff D, Almeyda J, Saleh HA. Measurement of absolute dimensions in endoscopic sinus surgery. Laryngoscope. May 2005;115(5):889-93. [Medline].

  22. Osguthorpe JD, Sofferman RA. Optic nerve decompression. Otolaryngol Clin North Am. Feb 1988;21(1):155-69. [Medline].

  23. Papay FA, Maggiano H, Dominquez S, Hassenbusch SJ. Rigid endoscopic repair of paranasal sinus cerebrospinal fluid fistulas. Laryngoscope. Nov 1989;99(11):1195-201. [Medline].

  24. Richtsmeier WJ. Top 10 reasons for endoscopic maxillary sinus surgery failure. Laryngoscope. Nov 2001;111(11 Pt 1):1952-6. [Medline].

  25. Romashko AA, Stankiewicz JA. Routine histopathology in uncomplicated sinus surgery: is it necessary?. Otolaryngol Head Neck Surg. Mar 2005;132(3):407-12; discussion 413. [Medline].

  26. Rowe-Jones JM, Medcalf M, Durham SR, Richards DH, Mackay IS. Functional endoscopic sinus surgery: 5 year follow up and results of a prospective, randomised, stratified, double-blind, placebo controlled study of postoperative fluticasone propionate aqueous nasal spray. Rhinology. Mar 2005;43(1):2-10. [Medline].

  27. Sanclement JA, Webster P, Thomas J, Ramadan HH. Bacterial biofilms in surgical specimens of patients with chronic rhinosinusitis. Laryngoscope. Apr 2005;115(4):578-82. [Medline].

  28. Stammberger H. Endoscopic endonasal surgery--concepts in treatment of recurring rhinosinusitis. Part I. Anatomic and pathophysiologic considerations. Otolaryngol Head Neck Surg. Feb 1986;94(2):143-7. [Medline].

  29. Stammberger H. Endoscopic endonasal surgery--concepts in treatment of recurring rhinosinusitis. Part II. Surgical technique. Otolaryngol Head Neck Surg. Feb 1986;94(2):147-56. [Medline].

  30. Stammberger H. Functional Endoscopic Sinus Surgery. Philadelphia:. BC Decker;1991.

  31. Stankiewicz JA. Blindness and intranasal endoscopic ethmoidectomy: prevention and management. Otolaryngol Head Neck Surg. Sep 1989;101(3):320-9. [Medline].

  32. Stankiewicz JA. Cerebrospinal fluid fistula and endoscopic sinus surgery. Laryngoscope. Mar 1991;101(3):250-6. [Medline].

  33. Stankiewicz JA. Complications of endoscopic sinus surgery. Otolaryngol Clin North Am. Aug 1989;22(4):749-58. [Medline].

  34. Wigand ME. Transnasal ethmoidectomy under endoscopical control. Rhinology. Mar 1981;19(1):7-15. [Medline].

  35. Wigand ME, Steiner W, Jaumann MP. Endonasal sinus surgery with endoscopical control: from radical operation to rehabilitation of the mucosa. Endoscopy. Nov 1978;10(4):255-60. [Medline].

  36. Wolf JS, Chiu AG, Palmer JN, O'Malley BW Jr, Schofield K, Taylor RJ. Informed consent in endoscopic sinus surgery: the patient perspective. Laryngoscope. Mar 2005;115(3):492-4. [Medline].

Further Reading

Keywords

functional endoscopic sinus surgery, FESS, chronic sinusitis, recurrent sinusitis, sinus infection, rhinosinusitis, chronic rhinosinusitis, rhinology, CSF leak, CSF rhinorrhea, inverted papilloma, orbital decompression, endoscopic DCR, optic nerve decompression, traumatic indirect optic neuropathy, sinus surgery

Contributor Information and Disclosures

Author

Ankit Patel, MD, Staff Physician, Department of Otolaryngology-Head and Neck Surgery, St Joseph Medical Center, Silver Cross Hospital
Ankit Patel, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery and American Rhinologic Society
Disclosure: a Salary Employment

Medical Editor

Lanny Garth Close, MD, Chair, Professor, Department of Otolaryngology-Head and Neck Surgery, Columbia University College of Physicians and Surgeons
Lanny Garth Close, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American College of Physicians, American Laryngological Association, American Society for Head and Neck Surgery, and New York Academy of Medicine
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Stephen G Batuello, MD, Consulting Staff, Colorado ENT Specialists
Stephen G Batuello, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Physician Executives, American Medical Association, and Colorado Medical Society
Disclosure: Nothing to disclose.

CME Editor

Christopher L Slack, MD, Otolaryngology-Facial Plastic Surgery, Private Practice, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders
Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association
Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine
Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society
Disclosure: Advanced Headache Intervention Consulting fee Consulting; Covidien Corp Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.